BioNTech SE’s Supervisory Board has appointed Jens Holstein to the Management Board as chief financial officer (CFO). As of July 1, 2021, Holstein will join the Management Board to help strengthen BioNTech on its growth trajectory as a global, fully integrated immunotherapy company with an approved or authorized product.   Holstein previously served as CFO for MorphoSys AG and in various CFO and general management roles within the Fresenius SE Group. Holstein takes over the CFO role from Dr. Sie...